Sao Paulo Med. J. vol.121 número1

CLZ (50 mg/day) was started in November 2013 and increased to 500 mg/day by the end of December, augmented with 6 mg of paliperidone, and the patient showed considerable

The aim of the present study was to determine the efficacy and safety of the therapeu- tic combination of 10 mg piroxicam, 1 mg dexamethasone, 35 mg orphenadrine citrate, and 2.5

Given the loss of therapeutic efficacy associated with the development of resistance to lamivudine (LMV) and the availability of new alterna- tive treatments for chronic hepatitis

Fluconazole trough plasma levels during the empirical dose regimen (200 mg twice daily, or 400 mg a day) in the irst period of drug therapy were used to determine the dose

codon 39 (C > T) mutations Centro de Biologia Molecular Estrutural e Engenharia Genética, in partnership with Hemocentro, Universidade Estadual de Campinas, Campinas, São

From the total group of 163 individuals, 90 (55.2%) considered crying as a potential factor for trig- gering attacks of headaches.. Of this group of 90 persons, 62 presented migraine

(Maternidade Escola de Vila Nova Cachoeirinha) and Instituto Dante Pazzanese de Cardiologia, São Paulo, Brazil.. CONTEXT: Leriche syndrome is a thrombotic oblit- eration of